Literature DB >> 36029408

PTMs: A Missing Piece for Schizophrenia Studies.

Caroline Brandão-Teles1, Bradley J Smith1, Victor Corasolla Carregari2.   

Abstract

One of the closest regulatory mechanisms to a cellular phenotype is post-translational modifications (PTMs), a diverse class of changes that proteins can undergo to change various physical and functional properties. PTMs hold great potential to better understand multifactorial diseases and disorders like schizophrenia. The field of PTMomics is still expanding and developing, though several modifications have already been implicated in the etiology and treatment of schizophrenia. Nonetheless, much has yet to be uncovered due to the vast number of modifications that occur on proteins. Here, some of the most well-supported arguments for PTM dysregulation in schizophrenia are raised, leaving the door open for multiple other modifications and their potential.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Post-translational modifications; Proteomics; Schizophrenia

Mesh:

Substances:

Year:  2022        PMID: 36029408     DOI: 10.1007/978-3-031-05460-0_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  59 in total

Review 1.  Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt?

Authors:  Kok Wei Lee; Puay San Woon; Yik Ying Teo; Kang Sim
Journal:  Neurosci Biobehav Rev       Date:  2011-09-17       Impact factor: 8.989

Review 2.  On the Dependency of Cellular Protein Levels on mRNA Abundance.

Authors:  Yansheng Liu; Andreas Beyer; Ruedi Aebersold
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

Review 3.  mRNAs, proteins and the emerging principles of gene expression control.

Authors:  Christopher Buccitelli; Matthias Selbach
Journal:  Nat Rev Genet       Date:  2020-07-24       Impact factor: 53.242

4.  Schizophrenia and the neurodevelopmental continuum:evidence from genomics.

Authors:  Michael J Owen; Michael C O'Donovan
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

5.  Is schizophrenia a neurodevelopmental disorder?

Authors:  R M Murray; S W Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

Review 6.  Schizophrenia: a neurodevelopmental disorder--integrative genomic hypothesis and therapeutic implications from a transgenic mouse model.

Authors:  M K Stachowiak; A Kucinski; R Curl; C Syposs; Y Yang; S Narla; C Terranova; D Prokop; I Klejbor; M Bencherif; B Birkaya; T Corso; A Parikh; E S Tzanakakis; S Wersinger; E K Stachowiak
Journal:  Schizophr Res       Date:  2012-12-08       Impact factor: 4.939

Review 7.  Insights into the regulation of protein abundance from proteomic and transcriptomic analyses.

Authors:  Christine Vogel; Edward M Marcotte
Journal:  Nat Rev Genet       Date:  2012-03-13       Impact factor: 53.242

8.  Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review.

Authors:  Diana P Prata; Bernardo Costa-Neves; Gonçalo Cosme; Evangelos Vassos
Journal:  J Psychiatr Res       Date:  2019-04-12       Impact factor: 4.791

Review 9.  Neurodevelopmental model of schizophrenia: update 2012.

Authors:  J L Rapoport; J N Giedd; N Gogtay
Journal:  Mol Psychiatry       Date:  2012-04-10       Impact factor: 15.992

10.  Neurodevelopmental hypothesis of schizophrenia.

Authors:  Michael J Owen; Michael C O'Donovan; Anita Thapar; Nicholas Craddock
Journal:  Br J Psychiatry       Date:  2011-03       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.